chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Glt flu vac 24 hrs later temp 103 pt have of 100 due thrombocytopenia (bone marrow pl). As I said in my email my mom had fever off and on for over one year. She is 92 and has a very high platelet count. We were told that the fever was most likely due to her underlying bone marrow condition. When she had her flu shot (only the 3rd in her life). She became very ill, higher fever than ever (shot Thursday pm-sick the night to Sunday night). Couldn't ear or drink on her own. On Monday morning she not only was better but was better than she had been in many months the fever never came back until 2 mo later just for 2 days. But this time related to Tylenol toxicity. She is fine now.
pt recv vax 21OCT96 & 16NOV96 pt exp a fever of about 101;19NOV96 pt devel over 40 vesicular pox;
pt recvd vax; on 12may94 devel inflammation & soreness at inject site; by 13may94 had completely recovered
pt recv vax  & the next day devel chickenpox, low grade fever, diarrhea, pink eye, runny rose;these dx persisted @ the date of this report, despite tx w/5 diff ATB;
PATIENT CAME TO THE PHARMACY AND REPORT THAT THERE IS REDNES AREA AROUND THE INJECTION SITE AND PAIN SENSATION WHEN TOUCH. THE PHARMACIST COUNSELED PATIENT THAT SHE CAN TAKE OTC PAIN MEDICATION SUCH AS TYLENOL OR ADVIL FOR A DAY OR TWO TO HELP WITH THE PAINS. THE PHARMACIST ALSO CALL PATIENT'S PCP AND REPORT ON THE ADVERSE REACTION.
Swelling to lips 2 days after receiving vaccine.  Treated with Benedryl with good relief at 10:30.
5 in area of warm, erythema, induration w/diffuse surrounding wheals extending to groin on right side. DECADRON, BENADRYL, warm compress. 2/21/19 erythema and swelling improving per mom.
Information has been received from a consumer concerning her daughter who on an unspecified date was vaccinated with a dose of MERUVAX II. Subsequently, "after getting vaccination", the patient developed rash, high fever, screaming and seizures. The outcome was not provided at this time. It was unspecified if the patient sought medical attention or not. The consumer also mentioned that her son had reaction to "the vaccine (name and manufacturer unknown)" (WAES # 0903USA04840). Upon internal review, seizure was considered to be an other important medical event. No further information is available.
Information has been received from a physician concerning a child who was vaccinated with varicella virus vaccine live. Last week, on approx 04SEP2003, the pt presented with chicken pox. It was reported that , at the time of the visit, the child was just breaking out so the doctor was unsure how many lesions the child had. Unspecified medical attention was sought. This physician also reported another pt, who developed chickenpox after vaccination with varicella virus vaccine live. Additional info has been requested.
Fever for 2 days and I?m having fatigue feeling everyday till my vaccine date sometimes little shortness of breath. Have leg pain. These feelings and pains occur different days.  Just took Tylenol no other medicines so far.
Full body rash - one day Searing burning skin in hands and face for 3.5 months Cognitive dysfunction - ongoing
Injection site is very red; injection site sore; injection site hot to the touch; i am dizzy; This case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th September 2021, the patient received the 1st dose of Shingrix. In September 2021, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site pain, injection site warmth and dizziness. On an unknown date, the outcome of the injection site erythema, injection site pain, injection site warmth and dizziness were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site pain, injection site warmth and dizziness to be related to Shingrix.  Additional details were provided as follows: The patient self reported this case. Age at vaccination was not reported. The patient received dose of Shingrix vaccine and experienced Injection site was very red and sore, hot to the touch, and dizziness. The follow-up would not possible as no contact details were available.
Information has been received from a physician concerning a 19 year old female patient who was vaccinated with a dose of Gardasil. The patient experienced joint pain after getting the injection. Unspecified medical attention was sought. Patient's outcome was unknown. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 5/14/2007. Initial and follow up information by telephone has been received from a physician concerning a 19 year old female patient who was vaccinated with a first and second dose of GARDASIL. The patient experienced joint pain after getting her second injection. Follow up information from the physician indicated that the patient had a positive ANA and an increased sed rate and he was trying to rule out the possibility of lupus. The physician requested additional information about GARDASIL and lupus and whether or not the patient should receive her third injection. On 30-APR-2007 the patient recovered. Additional information has been requested.
Patient received flu shot. Patient's mother returned shortly after stating her daughter should sit down because she felt she was going to pass out. Patient fainted after being seated. When patient lost conciousness, 911 was called. Patient may have also seized for a brief moment . Before 911 call finished, patient fully regained conciousness. Vitals taken once before paramedics arrived. Paramedics arrived and took family to the ambulance for observation. Ultimate outcome is unknown, patient's family not reachable - phone #'s in profiles not working.
Initial information has been received from a consumer concerning her 80 year old mother with diabetes (type unspecified) and a history of shingles in 2006 who on 23-AUG-2007 was vaccinated with zoster vaccine live (Oka/Merck). Concomitant therapy included insulin and VICODIN. On 09-MAR-2008, medical attention was sought in the hospital emergency room where the patient was diagnosed with shingles, there were no lab studies performed. The patient's daughter stated her mother was treated with VALTREX and discharged. The patient's daughter also stated that her mother had a severe case of shingles in 2006, that was located on the other side of her body from this current outbreak of shingles. At the time of the report the patient had not recovered. There was no product quality complaint involved. Follow-up information was received from the physician's office concerning an 80 year old consumer with diabetes (type unspecified), penicillin and BACTRIM allergies. On 23-AUG-2007, the patient was vaccinated SQ in the right deltoid with a single dose of zoster vaccine live (Oka/Merck) (lot # 656858/0356U). Additional concomitant therapy included PREVACID, aspirin, metformin, folic acid, losartan potassium (MSD), AMBIEN, and PLAVIX. Approximately seven months after vaccination, on 12-MAR-2008 (also reported as 09-Mar-2008 and 13-MAR-2008) the patient's left arm had an extensive red inflamed rash, with intermittent white blisters and numerous lesions, also reported as recurrent shingles on her left arm. It was unknown if the patient had a history of chickenpox or herpes zoster. The patient's pain was rated 6-7 on a scale of 0 (least) to 10 (most). The patient's maximum temperature was reported as 98.4. On 21-MAR-2008 the patient recovered. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) strain or with The OKA/Merck vaccine strain. The sample of a lesion was collected on 13-MAR-2008 and sent to the laboratory on 13-MAR-2008. The sample was taken from a unknown source. The PCR sample was an Inadequate Specimen, Negative for B-GLOBIN, No Strain I.D. Additional information is not expected.
Sore arm, prolonged fever lasting 32 hours so far, the fever has not subsided yet. Extreme tiredness, I have slept for almost 30 hours. Aches and a side ribs are sore. I also fainted and fell several times during the night.
2-3 days after receiving MMR, developed rash on face, neck, & both arms.  Very itchy. At time of office visit on 4/21/06 she had small, diffuse, 2mm raised erythemic spots to face, trunk, arms & legs, pruritic.  No signs of infection.  Afebrile.
Gums and tongue swelled. Skin turned pale and clammy. Left side of face drooped. Mom administered TYLENOL. Child afebrile, still eating, and breathing without difficulty per Mom.
received the 1st dose of the Pfizer covid vaccine on 22 Jan 2021/has not received her 2nd dose; neurological issues; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101777267 (Pfizer).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Time: 10:20 am), administration date: 22Jan2021, for COVID-19 immunization, reaction(s): "neurological issues". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "received the 1st dose of the Pfizer covid vaccine on 22Jan2021/has not received her 2nd dose"; NERVOUS SYSTEM DISORDER (non-serious), outcome "unknown", described as "neurological issues".  Additional information: Reporter was received the 1st dose of the Pfizer covid vaccine on 22Jan2021 at 10:20 am. That night, she had an ocular migraine for 7 days straight, ringing in her ear, pressure in the head, tachycardia that lasted 2 weeks, dizziness that turned to vertigo and she still has vertigo till this day She is now seeing a neurologist and taking medications. She was also seeing a vestibular specialist. She has not received her 2nd dose. Reporter was a patient, and a mother looking for advice about whether or not her children should take the Pfizer Covid vaccine. Reporter was stated that after she had neurological issues after receiving the Pfizer covid vaccine.  Follow-up attempts are completed. No further information is expected.
Brain fog and drowsiness 5 minutes after receiving vaccine, slight headache, fatigued later. Within the week, neck out of alignment (went to chiropractor), felt neck/head pulsing, felt like a muscle contraction, vascular issues, hard to breathe, hypoxia. For the first two weeks, legs felt like they had blocks on them, had to get a massage from massage therapist. Lacks energy
Skin lesions - erythem. papules on upper extremities and torso. Outbreak occurred 3 days ago. Some lesions are already crusted.
Arm hurt; Area where I received the shot is very hard like a big knot; Area where I received the shot is very hard like a big knot; Its always extra warm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Its always extra warm), VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE INDURATION (Area where I received the shot is very hard like a big knot) and VACCINATION SITE SWELLING (Area where I received the shot is very hard like a big knot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Its always extra warm), VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE INDURATION (Area where I received the shot is very hard like a big knot) and VACCINATION SITE SWELLING (Area where I received the shot is very hard like a big knot). At the time of the report, FEELING HOT (Its always extra warm) outcome was unknown and VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE INDURATION (Area where I received the shot is very hard like a big knot) and VACCINATION SITE SWELLING (Area where I received the shot is very hard like a big knot) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not provided. The area where the patient received the shot was very hard like a big knot  and its always extra warm . Treatment medication were not reported.
See Report Info: I have 2 knee implants and that was what was affected. They were so swollen and inflamed and swollen that I could not walk or get up out of a chair. I had to miss work the next day and had to use knee braces and an cane to walk. This lasted for two days. I called the Dr. and they said that this should not happen. I was in pain for 4 days and then it started to get better.
Soreness at the administration site; received the liquid diluent portion of Shingrix; received the liquid diluent portion of Shingrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered and inappropriate preparation of medication. The action taken with Shingrix was unknown. On an unknown date, the outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient might had just received the liquid diluent portion of Shingrix which led to inappropriate dose of vaccine administered and inappropriate preparation of medication. The reporter was consented to follow up. This is 1 of 4 cases reported by the same reporter.   Follow up information received from pharmacist on 25th February 2020: Four patients were identified as having received the Shingrix vaccine during the timeframe of the discovery of the single Shingrix vaccine in the box with no adjuvant. The patient's age was ranged between 50 years to 63 years. The patient received 1st dose of Shingrix. The patient might had just received the liquid diluent portion of Shingrix and the timeframe of the incident happened between 10th December 2019 through 06th January 2020. After receiving Shingrix, the patient had soreness at the administration site. No further symptoms or adverse reactions were reported. The vaccinator was questioned and said they reconstituted both components of the Shingrix vaccine. It was undetermined which patient out of 4 might have only received the adjuvant component of the Shingrix vaccine.
Patient's boyfriend was vaccinated on May 14th . Patient had sexual contact with boyfriend on May 23rd, and on May 27th, developed an itchy lump on the labia minor, near the clitoris. She sought medical attention on May 30th.  She had one nodular bump that was 1.1 X .6 mm in diameter. On May 31st, she reports that she had 2 additional bumps on the labia minora, right groin tenderness, malaise, nausea, and fever of 100.5 F.  On June 2nd, she sought medical care again with several more lesions (20+) on the labia minora, the labia majora and the clitoral hood, and a single pustule on the anterior thigh.  Patient is on oral contraceptives. No pelvic exam was performed due to the possibility of causing trauma and further spread of the lesions. She is being treated with hydroxyzene for itching.
GARDASIL GIVEN 8/6/08 IN RIGHT ARM. CAME IN ON 8/8/08 WITH SPECKLED RASH ON PLAM OF RIGHT HAND, SWOLLEN MILD UPPER RIGHT ARM WHERE SHOT WAS GIVEN. NOT PAINFUL, NO SIGNS OF INFECTION.
pt recv vax 29OCT97 & 30OCT97 4AM woke up itching;6AM noted hives on knees, legs, bottom of hands, wrist, elbows;mild itching;no problem breathing;called MD:3NOV to MD c/o n, legs totally swollen w/hives leg had burning sensation;
DtaP-Hib given before 15 months of age. No side effects reported.
One day post vax, the patient experienced a rash on her deltoid at the injection site which was described as a 3-4cm encrusted scab-like area. It was reported that the rash lasted for one week and that the patient recovered. Additional information has been requested.
shingles; Information has been received from a lawyer and a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2015, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a physician at a medical office for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event was unknown. The event was considered related to zoster vaccine live (ZOSTAVAX).
On Day 6 post vaccination, noticed slight tenderness near injection site. On Day 7 a rash developed and it was warm to the touch. On Day 8, some pain developed in addition. On Day 9, the rash grew in size and was itchy. On Day 10, it was almost cleared up. On Day 11, it appeared gone, On Day 12, the rash *re-appeared* but had grown in size. On Day 13, the rash was even bigger - had spread further down my arm. By Day 14, it had almost disppeared.  On Day 5, I noticed a swollen lymph node near my left clavicle. On Day 6, this lymph node had swelled and now there was pain. I also experienced slight discomfort under my left armpit. The pain associated with the clavicle lymph node lasted until Day 8. As of Day 14, the lymph node is still swollen.
Localized redness and swelling to left upper arm. Treatment: KEFLEX 250 mg/5mL, 4mL PO TID x 10 days.
1st noted redness size of nickel around site of injection. No pain or pruritis. Area of redness became larger than an egg & swelling approx. 1/4" depth. Felt hot to touch. Called Dr office & they rec BENADRYL & TYLENOL & ice."Did that for 2 days". 8/23 9:15 redness size quarter.
Came to health center complaining of itching and reports picking at arm for at least 1 day duration. Patient is cognitively impaired - difficult to determine date on onset.
Significant headache, abdominal pain, nausea, vomiting x 3.
hot flashes; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038k20a) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HOT FLUSH (hot flashes). At the time of the report, HOT FLUSH (hot flashes) outcome was unknown.            No concomitant medications was reported No treatment information was provided   This case was linked to MOD-2021-027162 (Patient Link).
Dizziness; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Injection site pain) and DIZZINESS (Dizziness) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced INJECTION SITE PAIN (Injection site pain). On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, INJECTION SITE PAIN (Injection site pain) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Patient was injected accidentally with an empty syringe (0.5 mL of air). Patient was notified immediately and given the vaccine in the same arm.
A major flare up of general herpes; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Unknown), dose 2 via an unspecified route of administration on 01Mar2021 (at the age of 50-year-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reported that after the second vaccination shot had a major recurrence. After the second dose of the vaccine, I had a major flare up of general herpes (01Mar2021) which I had not have a flare up of in over ten years so just wanna let you know that that will happen possibly and that was an adverse event part. The clinical outcome of event was unknown.  The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow up.
Armpits and sides painful hurting; tenderness in breast; swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6202), via an unspecified route of administration in the right arm on 26Feb2021 at 18:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Mar2021 at 01:00, the patient's armpits and sides were painful and hurting. The patient had tenderness in breast and the patient guessed that it might be swollen lymph nodes. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events armpits and sides painful hurting, tenderness in breast and swollen lymph nodes. The clinical outcomes of the events armpits and sides painful hurting, tenderness in breast and swollen lymph nodes were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.